Clinical Trial Update: A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial comparing standard of care to eMDPI DS in participants aged 13 and older with asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• eMDPI DS

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2023-03-14